Search

Search Constraints

You searched for: Author/Creator Ezekowitz, Michael D

Search Results

1. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score. (21st October 2017)

2. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. (27th September 2020)

3. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. Issue 5 (18th September 2018)

4. Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. Issue 6 (26th March 2020)

5. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation. Issue 5 (7th January 2020)

6. Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis. Issue 11 (22nd August 2019)

7. Disease understanding in patients newly diagnosed with atrial fibrillation. Issue 6 (8th August 2017)

9. Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Issue 10055 (22nd October 2016)

10. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Issue 1 (19th March 2021)